Publications by authors named "Ferras Alashkar"

Claim this Profile
S
Sutimlimab in Patients With Cold Agglutinin Disease (CAD): Results From a Managed Access Program.
Sandra Maria Frey, Pauline Halberstadt, Ferras Alashkar, Veronika Lenz, H Christian Reinhardt

Eur J Haematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors.
Antonio M Risitano, Austin G Kulasekararaj, Phillip Scheinberg, Alexander Röth, Bing Han, Ferras Alashkar

Lancet Haematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographics, clinical characteristics, and real-world treatment patterns among patients with beta-thalassemia: a retrospective medical record abstraction study.
Maria Domenica Cappellini, Mrudula B Glassberg, Juliana Meyers, Maria Jimenez, Tram Nham, Ferras Alashkar

Ther Adv Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Transition in sickle cell disease - recommendations of the transition initiative sickle cell disease].
Janine Böll, Ferras Alashkar, Carmen Aramayo-Singelmann, Anette Hoferer, Andrea Jarisch

Dtsch Med Wochenschr· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria.
Régis Peffault de Latour, Alexander Röth, Austin G Kulasekararaj, Bing Han, Phillip Scheinberg, Ferras Alashkar

N Engl J Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in a real-world setting.
Katharina Versmold, Ferras Alashkar, Carina Raiser, Richard Ofori-Asenso, Tao Xu

Eur J Haematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luspatercept, a two-edged sword in beta-thalassemia-associated paravertebral extramedullary hematopoietic masses (EHMs).
Ferras Alashkar, Hannes Klump, Cara Paulina Lange, Pia Proske, Maximilian Schüssler

Eur J Haematol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early report on the severity of COVID-19 in hematologic patients infected with the SARS-CoV2 omicron variant.
Fabian Ullrich, Christine Hanoun, Amin T Turki, Tobias Liebregts, Katharina Breuckmann, Ferras Alashkar

Eur J Haematol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired aplastic anemia following SARS-CoV-2 vaccination.
Alexander Röth, Stefanie Bertram, Thomas Schroeder, Thomas Haverkamp, Sebastian Voigt, Ferras Alashkar

Eur J Haematol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transition in Sickle Cell Disease (SCD): A German Consensus Recommendation.
Ferras Alashkar, Carmen Aramayo-Singelmann, Janine Böll, Annette Hoferer, Andrea Jarisch

J Pers Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectives.
Carmen Aramayo-Singelmann, Susan Halimeh, Pia Proske, Abinuja Vignalingarajah, Holger Cario, Ferras Alashkar

Sci Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of CMV reactivation on relapse of acute myeloid leukemia after HCT is dependent on disease stage and ATG.
Amin T Turki, Nikolaos Tsachakis-Mück, Saskia Leserer, Pietro Crivello, Tobias Liebregts, Ferras Alashkar

Blood Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancies and Neonatal Outcomes in Patients with Sickle Cell Disease (SCD): Still a (High-)Risk Constellation?
Pia Proske, Laura Distelmaier, Carmen Aramayo-Singelmann, Nikolaos Koliastas, Antonella Iannaccone, Ferras Alashkar

J Pers Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial.
Antonio M Risitano, Alexander Röth, Juliette Soret, Camilla Frieri, Flore Sicre de Fontbrune, Ferras Alashkar

Lancet Haematol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy in Classical Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia-Paroxysmal Nocturnal Hemoglobinuria: A High-Risk Constellation.
Ferras Alashkar, Fuat H Saner, Colin Vance, Ute Schmücker, Dörte Herich-Terhürne

Front Med (Lausanne)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial.
Christine Schmitz, Jan Rekowski, Stefan P Müller, Bernd Hertenstein, Christiane Franzius, Ferras Alashkar

Hematol Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved survival in metastatic breast cancer: results from a 20-year study involving 1033 women treated at a single comprehensive cancer center.
Anja Welt, Simon Bogner, Marina Arendt, Josef Kossow, Antonia Huffziger, Ferras Alashkar

J Cancer Res Clin Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence for hypogammaglobulinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with ravulizumab.
Ferras Alashkar, Scott Rottinghaus, Colin Vance, Dörte Herich-Terhürne, Ulrich Dührsen

PLoS One· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Veno-Venous Extracorporeal Membrane Oxygenation in Adult Patients with Sickle Cell Disease and Acute Chest Syndrome: a Single-Center Experience.
Ferras Alashkar, Frank Herbstreit, Alexander Carpinteiro, Julia Baum, Asterios Tzalavras

Hemoglobin· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serologic response to meningococcal vaccination in patients with cold agglutinin disease (CAD) in the novel era of complement inhibition.
Ferras Alashkar, Colin Vance, Dörte Herich-Terhürne, Amin T Turki, Christine Schmitz

Vaccine· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunosuppressive therapy (IST) in adult patients with acquired aplastic anemia (AA): A single-center experience over the past 15 years.
Ferras Alashkar, Maren Oelmüller, Dörte Herich-Terhürne, Amin T Turki, Christine Schmitz

Eur J Haematol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial.
Andreas Hüttmann, Jan Rekowski, Stefan P Müller, Bernd Hertenstein, Christiane Franzius, Ferras Alashkar

Ann Hematol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Platelet number and graft function predict intensive care survival in allogeneic stem cell transplantation patients.
Amin T Turki, Wolfgang Lamm, Christoph Schmitt, Evren Bayraktar, Ferras Alashkar

Ann Hematol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet number and graft function predict intensive care survival in allogeneic stem cell transplantation patients.
Amin T Turki, Wolfgang Lamm, Christoph Schmitt, Evren Bayraktar, Ferras Alashkar

Ann Hematol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Whole-Body Magnetic Resonance Imaging (WB-MRI) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH).
Ferras Alashkar, Haemi Phaedra Schemuth, Felix Nensa, Juliane Göbel, Colin Vance

Sci Rep· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis